Transl Clin Pharmacol.  2018 Sep;26(3):115-117. 10.12793/tcp.2018.26.3.115.

Mechanistic ligand-receptor interaction model: operational model of agonism

Affiliations
  • 1Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul 05505, Republic of Korea. mdlhs@amc.seoul.kr

Abstract

This tutorial explains the basic principles of mechanistic ligand-receptor interaction model, which is an operational model of agonism. A growing number of agonist drugs, especially immune oncology drugs, is currently being developed. In this tutorial, time-dependent ordinary differential equation for simple E(max) operational model of agonism was derived step by step. The differential equation could be applied in a pharmacodynamic modeling software, such as NONMEM, for use in non-steady state experiments, in which experimental data are generated while the interaction between ligand and receptor changes over time. Making the most of the non-steady state experimental data would simplify the experimental processes, and furthermore allow us to identify more detailed kinetics of a potential drug. The operational model of agonism could be useful to predict the optimal dose for agonistic drugs from in vitro and in vivo animal pharmacology experiments at the very early phase of drug development.

Keyword

Mechanistic ligand-receptor interaction; Operational model of agonism; Optimal dose; Prediction

MeSH Terms

Animals
Felodipine*
In Vitro Techniques
Kinetics
Pharmacology
Felodipine

Reference

1. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006; 355:1018–1028. PMID: 16908486.
Article
2. Salahudeen MS, Nishtala PS. An overview of pharmacodynamics modelling, ligand-binding approach and its application in clinical practice. Saudi Pharm J. 2017; 25:165–175. DOI: 10.1016/j.jsps.2016.07.002. PMID: 28344466.
3. Black JW, Leff P. Operational model of pharmacological agonism. Proc R Soc Lond B Biol Sci. 1983; 220:141–162. PMID: 6141562.
4. Black JW, Leff P, Shankley NP, Wood J. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol. 1985; 84:561–571. PMID: 3978322.
Article
Full Text Links
  • TCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr